Stablecoin Development Corp. specializes in manufacturing and distributing eye and skin health solutions that have undergone rigorous scientific development and proven efficacy ...
Stablecoin Development Corporation (NYSE American: SDEV), formerly NovaBay Pharmaceuticals, Inc., is a healthcare company that has pivoted to become an on-chain holding company focused on long-duration participation in protocol-aligned digital asset ecosystems. The company, incorporated in 2000 and headquartered in Emeryville, California, is led by CEO Michael Kazley. With a ...Stablecoin Development Corporation (NYSE American: SDEV), formerly NovaBay Pharmaceuticals, Inc., is a healthcare company that has pivoted to become an on-chain holding company focused on long-duration participation in protocol-aligned digital asset ecosystems. The company, incorporated in 2000 and headquartered in Emeryville, California, is led by CEO Michael Kazley. With a small team of 4 employees, SDEV operates in the healthcare sector but is transitioning its business model toward stablecoin development and digital asset strategies. Its product portfolio historically includes scientifically-developed eye and skin health solutions, such as Avenova and NeutroPhase, which have demonstrated efficacy in clinical settings. Financially, SDEV trades at a low market capitalization of around $52 million, with significant net income per share of $15.57 and a dividend yield of 3.85%. The company has high gross profit margins (99%) and a strong current ratio of 28.9, indicating robust liquidity. However, it exhibits negative operating cash flow and free cash flow, reflecting ongoing operational challenges. The strategic pivot to blockchain and stablecoins suggests a forward-looking approach, aiming to leverage the growing digital asset market. The company's website (stabledev.com) and public communications emphasize its commitment to building a publicly traded platform within the stablecoin ecosystem, beginning with a strategic position in Sky. Despite its limited workforce, SDEV is positioning itself at the intersection of healthcare and blockchain, which may attract investors interested in both sectors. The company's unique dual focus could provide diversification but also introduces risks related to regulatory changes in the crypto space and the volatility of digital assets.
YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength.
QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes.
RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three).
$0
—
-10.4%
Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day.
$-642.0M
-8788.0%
-107.4%
Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials.
—
—
0.0%
Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on).
—
—
-831.2%
Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales.
—
—
-108.3%
Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock.
$-8.4M
-12.4%
-230.7%
FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine.
—
—
-269.2%
Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe.
-3.4%
+99.7%
-100.0%
Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking.
7.39x
+985.1%
+467.1%
Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground.